Variant · Snv
MORC2 NM_001303256.3(MORC2):c.966A>T (p.Gly322=)
CI-VAR-00080645Explore in graph →p.Gly322=NM_001303256.3:c.966A>TClinVar 475601 rs16989204
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 475601 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Charcot-Marie-Tooth disease axonal type 2Z; Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy; MORC2-related disorder; Hepatocellular carcinoma; Malignant tumor of esophagus; Lung cancer; Cervical cancer; Uterine carcinosarcoma; Thyroid cancer, nonmedullary, 1; Thymoma; Acute myeloid leukemia; Clear cell carcinoma of kidney; Ovarian serous cystadenocarcinoma | germline | 7 | Feb 02, 2026 | clinvar |